Disease Applications
Therapeutic Vaccines
Etubics is developing immunotherapies for cancers such as breast, colon and head and neck cancers caused by HPV.
According
to the American Cancer Society, cancer is the leading cause of death
worldwide, accounting for 7.4 million deaths in 2009, with colon and
breast cancer being among the most prevalent. Deaths from cancer
worldwide are projected to continue rising, with an estimated 12
million in 2030.
Prophylactic Vaccines
Etubics' prophylactic vaccines are focused on infectious diseases, such as influenza, malaria and HIV.